Trial Profile
Phase II, Parallel-group, Placebo Controlled, Double-blind, Randomised, Multicenter Study to Investigate the Efficacy of Two Dosages of Propionyl-L-Carnitine Colon Release Tablets in Patients Affected by Ulcerative Colitis Under Oral Stable Treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jun 2017
Price :
$35
*
At a glance
- Drugs Propionyl carnitine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 11 Oct 2011 New trial record